3 reasons this paper matters, starting with the least obvious.
The sneaky one is that Alzheimer's may begin by changing the emotional soundtrack before it mangles the plot. Not just forgotten names or lost keys - anxiety that feels sharper, apathy that lands heavier, irritability that shows up uninvited like a guy with an acoustic guitar at a party. In this new Neuron perspective, Adam Turnbull, James Gross, and Feng Vankee-Lin argue that some early neuropsychiatric symptoms in preclinical Alzheimer's may emerge because the brain's emotion-regulation machinery starts losing the groove before classic dementia symptoms take center stage (Turnbull et al., 2026).
The Brain's House Band Starts Missing Notes
The paper's core idea is elegant. Parts of the brain involved in emotion regulation - especially the ventral anterior cingulate cortex and ventromedial prefrontal cortex, or vmPFC - may get hit early by Alzheimer's pathology. That matters because those regions help you revise emotional reactions based on experience.
Think of it like this: your brain usually runs a quiet little jazz trio in the background. Bad thing happens, your body flinches, and then the band settles the room down. "We've seen this tune before," it says. "No need for a full drum solo." One way it does that is through something researchers call model-free emotion regulation - basically, learned emotional updating through repetition and reinforcement, including fear extinction. You stop treating every creak in the house like the opening scene of a horror movie.
Turnbull and colleagues suggest that early Alzheimer's may disrupt exactly that system. If the vmPFC can't damp down negative value as well, ordinary stressors can start feeling louder, sharper, more expensive. Same world, harsher soundtrack.
That idea is not coming out of nowhere. A 2024 review on vmPFC function described the region as central to emotion regulation and fear-related valuation, which fits this paper's wiring diagram rather well (Alexander et al., 2023). And a 2024 study in people with preclinical Alzheimer's found that amyloid-positive participants showed more tau in parts of the amygdala, with links to anxiety symptoms and altered connectivity in emotion-related circuits (Li et al., 2024). The rhythm section, in other words, already looks a little shaky.
Autopilot Fades, Manual Steering Gets Expensive
The paper adds a second riff: when the brain's more automatic regulation stops carrying its share, the more effortful system has to compensate.
That's model-based emotion regulation - the deliberate, mentally taxing kind. Reframing. Suppressing. Talking yourself down. The "let me be mature about this" layer. It works, but it burns executive resources, and preclinical Alzheimer's is not exactly famous for leaving those untouched.
So now imagine your brain trying to calm a rising emotional storm using the cognitive equivalent of a laptop at 4% battery. It can still open the file. It just makes a noise like it's negotiating with death.
This matters because it helps explain why symptoms may be worse in messy real life than in neat laboratory tasks. A person might look mostly fine on paper while daily stress, uncertainty, noise, multitasking, and fatigue turn emotion regulation into a clumsy improv set with no chord chart.
Other recent work points in the same direction. A 2024 study found reduced sensitivity to effort in both Alzheimer's disease and subjective cognitive impairment, suggesting that motivation and cost-benefit processing are already getting weird early on (Attaallah et al., 2024). Another 2024 longitudinal study linked greater tau burden in Alzheimer's-related brain regions to increasing apathy over time (Premnath et al., 2024). Different symptom, same musical motif: the circuits that help you care, adapt, and regulate may be under strain before the marquee symptoms fully arrive.
Why This Is More Than a Mood Story
Here's the bigger swing: if mood and behavior changes are part of the disease process early on, they are not side quests. They may be clues, maybe even leverage points.
That lines up with what clinicians already see. The Alzheimer's Association notes that depression, anxiety, agitation, and apathy are common across the disease course, and recent reviews argue that neuropsychiatric symptoms deserve to be treated as core features, not decorative extras stapled onto memory decline. A 2025 systematic review, for example, found a fast-growing but still fragmented biomarker literature linking neuropsychiatric symptoms to Alzheimer's-related biology (Perini et al., 2025). Translation: the field has the band, the instruments, and half the sheet music. It still needs a tighter arrangement.
If this perspective holds up, it could reshape intervention. Instead of waiting for memory failure to become undeniable, researchers might test whether strengthening emotion regulation, reducing chronic negative affect, or targeting affected circuits earlier could improve quality of life and maybe even nudge progression. Not cure, not magic, not "one weird trick neurologists hate." Just a smarter map.
Keep the Champagne Corked
There is a catch, because there is always a catch. This paper is a perspective, not a clinical trial. It offers a strong framework, not final proof. Alzheimer's is messy, symptoms vary, and mood changes can come from many causes besides neurodegeneration. The authors are careful about that, and so should we be.
Still, this is the kind of paper that changes the conversation. It treats emotion not as background static but as part of the signal. And honestly, that feels overdue. Alzheimer's has long been framed as a memory story. This paper says: listen closer. The brain may be going out of tune emotionally before it forgets the melody.
References
-
Turnbull A, Gross JJ, Vankee-Lin F. The emergence of neuropsychiatric symptoms in preclinical Alzheimer's disease: An emotion regulation perspective. Neuron. 2026. DOI: https://doi.org/10.1016/j.neuron.2026.01.022. PubMed: https://pubmed.ncbi.nlm.nih.gov/41812658/
-
Li JS, et al. Medial amygdalar tau is associated with anxiety symptoms in preclinical Alzheimer's disease. 2024. DOI: https://doi.org/10.1101/2024.06.03.597160. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC11185761/
-
Premnath PY, et al. Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2024;10(1):e12442. DOI: https://doi.org/10.1002/trc2.12442. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC10865481/
-
Attaallah B, Toniolo S, Maio MR, Husain M. Apathy and effort-based decision-making in Alzheimer's disease and subjective cognitive impairment. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2024;16(4):e70013. DOI: https://doi.org/10.1002/dad2.70013. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC11480904/
-
Alexander L, Wood CM, Roberts AC. The ventromedial prefrontal cortex and emotion regulation: lost in translation? The Journal of Physiology. 2023;601(1):37-50. DOI: https://doi.org/10.1113/JP282627. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC10084434/
-
Perini G, et al. BIOmarkers in NEuropsychiatric SYmptoms (BIONESY): A multicenter nation survey and a systematic review. Journal of Geriatric Psychiatry and Neurology. 2025. DOI: https://doi.org/10.1177/13872877251344631
-
Alzheimer's Association. Anxiety & Agitation. https://www.alz.org/Help-Support/Caregiving/Stages-Behaviors/Anxiety-Agitation
Disclaimer: This blog post is a simplified summary of published research for educational purposes. The accompanying illustration is artistic and does not depict actual model architectures, data, or experimental results. Always refer to the original paper for technical details.